Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00052962 · ClinicalTrials.gov registry record · Phase 3
Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
A Phase 3 study of Gastrointestinal Neoplasm, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00052962 is a Phase 3 study of Gastrointestinal Neoplasm that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 30 participants, below the 109-participant average among 4 other Gastrointestinal Neoplasm trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00052962, a Phase 3 study of Gastrointestinal Neoplasm, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine which of the two following treatment regimens provides greater benefit to patients with peritoneal carcinomatosis (gastrointestinal cancer that has spread throughout the abdomen): * Surgical removal of tumors plus heated chemotherapy during surgery, followed by one dose of chemotherapy 7 to 12 days after surgery, followed 3 weeks later by 4 months of chemotherapy; or * Surgical removal of tumors followed by 4 months of chemotherapy, starting 1 month after surgery. Patients 18 years of age and older with peritoneal carcinomatosis may be eligible for this study. Candidates are screened with a medical history, physical examination, and blood tests; chest X-ray and computed tomography (CT) scans; review of pathology slides; electrocardiogram (EKG), bone scan, and brain magnetic resonance imaging (MRI), as needed; and laparotomy. Laparatomy is a surgical procedure in which an incision is made in the abdomen to look at the amount and location of tumors in the abdominal cavity. Patients whose surgery reveals that the tumors cannot be removed are taken off study. Those eligible for the study have their tumors removed during this screening laparotomy as part of the study procedure, as follows: All participants undergo laparotomy and removal of as much tumor as possible, as described above. Patients are then randomly assigned to one of two treatment groups: * Group 1 - During laparotomy, after tumor removal, patients receive continuous hyperthermic peritoneal perfusion (CHPP) with the anti-cancer drug cisplatin. For CHPP, the cisplatin solution is heated and delivered to the abdomen through a catheter (plastic tube), washed through the abdomen for 90 minutes, and then drained out of the body through another catheter. At the close of surgery, a small catheter, called a Tenckhoff catheter, is left in the abdomen and brought out through the skin. Between days 7 and 12 after surgery, one dose of fluorouracil and paclitaxel chemotherapy is delivered t
Conditions Studied
Interventions
- PROCEDURE Cytoreductive surgery
- PROCEDURE Continuous hyperthermic peritoneal perfusion (HIPEC/CHPP)
Study Locations (1)
Maryland
- National Cancer Institute (NCI) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2003-01 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00052962
The ClinicalTrials.gov registry entry for NCT00052962 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109-participant average among 4 other Gastrointestinal Neoplasm trials with a reported enrollment target (72% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastrointestinal Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Cytoreductive surgery is the first listed.
NCT00052962 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00052962 about?
NCT00052962 is a clinical study titled "Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis". This study will determine which of the two following treatment regimens provides greater benefit to patients with peritoneal carcinomatosis (gastrointestinal cancer that has spread throughout the abdomen): * Surgical removal of tumors plus heated chemotherapy during surgery, followed by one dose of...
What is the current status of trial NCT00052962?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2003-01. Estimated completion is 2008-09.
What conditions does trial NCT00052962 study?
This clinical trial studies the following conditions: Gastrointestinal Neoplasm.
What interventions are being tested in trial NCT00052962?
The interventions under investigation include: Cytoreductive surgery (PROCEDURE), Continuous hyperthermic peritoneal perfusion (HIPEC/CHPP) (PROCEDURE).
Who is sponsoring clinical trial NCT00052962?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00052962 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AI for Onsite Cytology Evaluation in Endoscopic Ultrasound
RECRUITING
-
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
RECRUITING · NA
-
Traction vs. No Traction in Colonic ESD
RECRUITING · NA
-
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.